GB/T 16886.14-2003
Biological evaluation of medical devices--Part 14: Identification and quantification of degradation products from ceramics (English Version)

Standard No.
GB/T 16886.14-2003
Language
Chinese, Available in English version
Release Date
2003
Published By
General Administration of Quality Supervision, Inspection and Quarantine of the People‘s Republic of China
Latest
GB/T 16886.14-2003
Scope
This part of GB/T 16886 specifies two methods for obtaining solutions for the quantification of degradation products from ceramic materials (including glass). In addition, guidance is given for analyzing these solutions to characterize degradation products. Because this part of GB/T 16886 is a general standard, if there is a specific product standard that discusses the formation of degradation products that is closer to the use conditions, it should be given priority. This part of GB/T 16886 only considers the degradation products produced by chemical dissociation of ceramic materials during in vitro tests, and does not consider the degradation caused by mechanical stress or external energy. It should be noted that while ISO 6872 and ISO 9693 specify chemical degradation tests, they do not specify methods for analyzing degradation products. Due to the wide range of ceramic materials used in medical devices and the varying requirements for precision and accuracy of results, no specific analytical technique is specified. This part of GB/T 16886 does not specify specific requirements for acceptable levels of degradation products. Although these materials will be used in biomedicine, this part of GB/T 16886 does not specify the biological activity of degradation products.

GB/T 16886.14-2003 history

  • 2003 GB/T 16886.14-2003 Biological evaluation of medical devices--Part 14: Identification and quantification of degradation products from ceramics
Biological evaluation of medical devices--Part 14: Identification and quantification of degradation products from ceramics

GB/T 16886.14-2003 -All Parts

GB/T 16886.1-2022 Biological evaluation of medical devices—Part 1: Evaluation and testing within a risk management process GB/T 16886.10-2017 Biological evaluation of medical devices—Part 10: Tests for irritation and skin sensitization GB/T 16886.11-2021 Biological evaluation of medical devices—Part 11: Tests for systemic toxicity GB/T 16886.12-2023 Biological Evaluation of Medical Devices Part 12: Sample Preparation and Reference Materials GB/T 16886.13-2017 Biological evaluation of medical devices—Part 13: Identification and quantification of degradation products from polymeric medical devices GB/T 16886.14-2003 Biological evaluation of medical devices--Part 14: Identification and quantification of degradation products from ceramics GB/T 16886.15-2022 Biological evaluation of medical devices—Part 15: Identification and quantification of degradation products from metals and alloys GB/T 16886.16-2021 Biological evaluation of medical devices—Part 16: Toxicokinetic study design for degradation products and leachables GB/T 16886.17-2005 Biological evaluation of medical devices.Part 17:Establishment of allowable limits for leachable substances GB/T 16886.18-2022 Biological evaluation of medical devices—Part 18: Chemical characterization of medical device materials within a risk management process GB/T 16886.19-2022 Biological evaluation of medical devices—Part 19: Physico-chemical, morphological and topographical characterization of materials GB/T 16886.2-2011 Biological evaluation of medical devices.Part 2: Animal welfare requirements GB/T 16886.20-2015 Biological evaluation of medical devices.Part 20:Principles and methods for immunotoxicology testing of medical devices GB/T 16886.23-2023 Biological Evaluation of Medical Devices Part 23: Stimulation Test GB/T 16886.3-2019 Biological evaluation of medical devices—Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity GB/T 16886.4-2022 Biological evaluation of medical devices—Part 4: Selection of tests for interactions with blood GB/T 16886.5-2017 Biological Evaluation of Medical Devices Part 5: In Vitro Cytotoxicity Tests GB/T 16886.6-2022 Biological evaluation of medical devices—Part 6:Tests for local effects after implantation GB/T 16886.7-2015 Biological evaluation of medical devices—Part 7: Ethylene oxide sterilization residuals GB/T 16886.9-2022 Biological Evaluation of Medical Devices Part 9: Qualitative and Quantitative Framework for Potential Degradation Products



Copyright ©2024 All Rights Reserved